Convallaria majalis L. is a perennial plant belonging to the family Liliaceae and is distributed in Europe, Asia, and North America. Its rhizomes are known to contain several cardenolide glycosides 1) and were used as a cardiotonic agent. However, this plant is cultivated only for ornamental purposes because an extract prepared from the rhizomes showed potent toxicity and produced harmful side effects on the heart. A literature survey concerning the secondary metabolites of C. majalis showed that it has been suggested to contain steroidal saponins, 2,3) as well as cardenolide glycosides, but no systematic phytochemical examinations have been carried out on this plant. The present investigation on the steroidal glycoside constituents of the rhizomes of C. majalis has resulted in the isolation of a new 5b-spirostanol triglycoside, named convallasaponin A, (1), along with two known cardenolide glycosides (2, 3) and a known cholestane glycoside (4). The paper deals with the structure elucidation of convallasaponin A (1) on the basis of extensive spectroscopic analysis, including 2D NMR data, and the results of hydrolytic cleavage. The cytotoxic activities of 1-4 against human submandibular gland carcinoma (HSG) cells and human periodontal ligament fibroblasts (HPLF) are also described.
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Results and Discussion
The fresh rhizomes of C. majalis L. were extracted with hot MeOH, and the MeOH extract was passed through a porous-polymer polystyrene resin (Diaion HP-20) column. A series of chromatographic separations of the 80% MeOH eluate fraction, in which steroidal glycosides were enriched, resulted in the isolation of compounds 1 (14.1 mg), 2 (173 mg), 3 (63.1 mg), and 4 (39.1 mg). Compounds 2-4 were identified as 5b,14b-dihydroxy-19-oxo-3b-[(a-L-rhamnopyranosyl)oxy]card-20,22-enolide (convallatoxin), 4) and 5b ,14b ,19-trihydroxy-3b -[(a -L-rhamnopyranosyl)oxy]card-20,22-enolide (convallatoxol), 4) and 5) respectively. This is the first isolation of glycoside of a cholestane derivative from C. majalis.
Convallasaponin A (1) was isolated as an amorphous solid and showed an accurate [MϩH] ϩ ion at m/z 889.4843 in the high-resolution electronspray-ionization mass spectrum (HR-ESI-MS), corresponding to the empirical molecular formula Identification of these sugars, including their absolute configuration, was carried out by direct HPLC analysis of the hydrolysate. The above data and an acetalic 13 C-NMR signal at d 110.3 6) suggested that 1 is a spirostanol triglycoside. The 13 C-NMR spectrum of 1 showed a total of 44 resonance lines, 17 of which were attributed to the sugar units. This implied a C 27 H 44 O 5 molecular formula for the aglycone moiety, indicating that three oxygen atoms were incorporated into the spirostane skeleton. (Fig. 1) . Although the genuine aglycone of 1 could not be obtained by acid hydrolysis, all of these data indicated that the aglycone of 1 is (25S)-5b-spirostane-1b,3b,17a-triol, which is a new steroidal sapogenin.
Finally, our attention was directed to the structure of the sugar moiety and its linkage position to the aglycone. The All the proton signals for the sugar moiety thus assigned were associated with one-bond coupled carbon signals using the HMQC spectrum. The glucosyl and xylosyl residues were considered to be the terminal units, as shown by the absence of any glycosylation shifts for their carbon signals, while the C-2 and C-3 hydroxy groups of the quinovosyl unit were suggested to be substituted by comparison of the 13 C-NMR shifts with those reported in the literature. 7) In the HMBC spectrum, the anomeric protons at d 5.13 (glucosyl) and 4.85 (xylosyl) showed long-range correlations with C-2 (d 80.6) and C-3 (d 88.1) of the quinovosyl moiety, respectively, whose anomeric proton at d 4.55, in turn, showed an HMBC correlation with C-1 (d 78.9) of the aglycone. On the basis of the above data, convallasaponin A (1) was assumed to be a combination of a new steroidal sa- pogenin and a new triglycoside, and the full structure of 1 was formulated elucidated as (25S)-3b,17a-dihydroxy5b-spiorstan-1b-yl
O-b-D-glucopyranosyl-(1→2)-O-[b-Dxylopyranosyl-(1→3)]-b-D-quinovopyranoside.
Several cardenolides and bufadienolides have been reported to show cytotoxic activity against cultured tumor cells. 8, 9) The cardenolide glycosides (1, 2) also exhibited potent cytotoxic activity against HSG cells with IC 50 values at 0.012 and 0.028 mg/ml, respectively, whereas 1 and 2 did not cytotoxic to normal HPLF at a sample concentration of 0.10 mg/ml.
